Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 6
2009 7
2010 9
2011 7
2012 18
2013 18
2014 21
2015 27
2016 39
2017 28
2018 37
2019 34
2020 44
2021 37
2022 30
2023 16
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

328 results

Results by year

Filters applied: . Clear all
Page 1
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study.
Christ SM, Alongi F, Ricardi U, Scorsetti M, Livi L, Balermpas P, Lievens Y, Braam P, Jereczek-Fossa BA, Stellamans K, Ratosa I, Widder J, Peulen H, Dirix P, Bral S, Ramella S, Hemmatazad H, Khanfir K, Geets X, Jeene P, Zilli T, Fournier B, Ivaldi GB, Clementel E, Fortpied C, Oppong FB, Ost P, Guckenberger M. Christ SM, et al. Among authors: alongi f. Radiother Oncol. 2024 Mar 19;195:110235. doi: 10.1016/j.radonc.2024.110235. Online ahead of print. Radiother Oncol. 2024. PMID: 38508239
ONE SHOT - single shot radiotherapy for localized prostate cancer: 18-month results of a single arm, multicenter phase I/II trial.
Zilli T, Franzese C, Guckenberger M, Giaj-Levra N, Mach N, Koutsouvelis N, Achard V, Mcdonald A, Alongi F, Scorsetti M, Constantin G, Bertaut A, Miralbell R. Zilli T, et al. Among authors: alongi f. Radiother Oncol. 2024 May;194:110181. doi: 10.1016/j.radonc.2024.110181. Epub 2024 Feb 24. Radiother Oncol. 2024. PMID: 38403022 Free article. Clinical Trial.
Radiotherapy of Oligometastatic Cancers.
Alongi F, Gaito S. Alongi F, et al. Cancers (Basel). 2024 Jan 24;16(3):511. doi: 10.3390/cancers16030511. Cancers (Basel). 2024. PMID: 38339262 Free PMC article.
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E2-RADIatE OligoCare cohort.
Bultijnck R, Van Hemelrijck M, Fonteyne V, Livi L, Jereczek-Fossa BA, Hemmatazad H, Mayinger M, Peulen H, Verbeke L, Ramella S, Castro P, Tsoutsou P, Stellamans K, Shaukat A, Orazem M, Jeene P, Braam P, Verkooijen H, Simek IM, Alongi F, Clementel E, Fortpied C, Machingura A, Boakye Oppong F, Guckenberger M, Ost P. Bultijnck R, et al. Among authors: alongi f. Clin Transl Radiat Oncol. 2023 Dec 29;45:100715. doi: 10.1016/j.ctro.2023.100715. eCollection 2024 Mar. Clin Transl Radiat Oncol. 2023. PMID: 38274388 Free PMC article.
MR-LINAC, a New Partner in Radiation Oncology: Current Landscape.
Ocanto A, Torres L, Montijano M, Rincón D, Fernández C, Sevilla B, Gonsalves D, Teja M, Guijarro M, Glaría L, Hernánz R, Zafra-Martin J, Sanmamed N, Kishan A, Alongi F, Moghanaki D, Nagar H, Couñago F. Ocanto A, et al. Among authors: alongi f. Cancers (Basel). 2024 Jan 8;16(2):270. doi: 10.3390/cancers16020270. Cancers (Basel). 2024. PMID: 38254760 Free PMC article. Review.
The state-of-the-art technic of stereotactic radioablation for the treatment of cardiac arrhythmias: An overview.
MasoudKabir F, Bayani R, Mousavi Darzikolaee N, Abdshah A, Moshtaghian M, Farhan F, Aghili M, Kazemian A, Nicosia L, Cuccia F, Rocha AV, Jafari F, Alongi F. MasoudKabir F, et al. Among authors: alongi f. Health Sci Rep. 2023 Dec 8;6(12):e1741. doi: 10.1002/hsr2.1741. eCollection 2023 Dec. Health Sci Rep. 2023. PMID: 38078303 Free PMC article.
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO).
Francolini G, Allegra AG, Detti B, Di Cataldo V, Caini S, Bruni A, Ingrosso G, D'Angelillo RM, Alitto AR, Augugliaro M, Triggiani L, Parisi S, Facchini G, Banini M, Simontacchi G, Desideri I, Meattini I, Valicenti RK, Livi L; ARTO Working Group members. Francolini G, et al. J Clin Oncol. 2023 Dec 20;41(36):5561-5568. doi: 10.1200/JCO.23.00985. Epub 2023 Sep 21. J Clin Oncol. 2023. PMID: 37733977 Clinical Trial.
328 results